Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry ... - MarketWatch (press release) |
 |
 |
|
MarketWatch (press release) SELZENTRY should not be used in patients with severe renal impairment or end-stage renal disease (ESRD) (CrCl <30 mL/min) who are taking potent CYP3A inhibitors or inducers. Hepatotoxicity accompanied by severe rash or systemic allergic reaction |
